Is #Parkinsons simply "one phenotypic expression of brain aging rather than a discrete disease entity"? & could this reconceptualization "improve biomarker development, clinical trial design, & patient communication"?
www.prd-journal.com/article/S135...
www.prd-journal.com
The boundary between aging and neurodegenerative disorders remains unresolved, and
emerging evidence challenges this dichotomy. Parkinson's disease (PD) has traditionally
been defined as a neurodegene...
